Back
Speaker illustration

Associate Professor Lorenz H Lehmann

University Hospital Heidelberg, Heidelberg (Germany)

Presentations

Targeted cardiac inactivation of Guanylate binding protein 5 (GBP5) protects from cardiotoxicity after doxorubicin treatment

Event: ESC Cardio-Oncology 2025

Topic: Research and New Technology

Session: Insights into anthracycline-induced cardiotoxicity and treatment perspectives

Access
Like
Thumbnail

Exercise and transient heart failure

Event: Heart Failure 2018

Topic: Cardiac Biology and Physiology

Session: Stress-induced heart failure

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources